MyFinsight
Home
About
Contact
rgnx: the income statement
Download
Download image
Unrealized gain on
available-for-sale securities, net
$98K
(-94.18%↓ Y/Y)
Comprehensive loss
-$61,843K
(-6.79%↓ Y/Y)
Total other
comprehensive income
$98K
(-94.18%↓ Y/Y)
Net loss
-$61,941K
(-3.93%↓ Y/Y)
Service
$6,128K
License And Service
$23,605K
Total other income
(expense)
-$9,530K
(-484.12%↓ Y/Y)
Loss from operations
-$52,411K
(15.57%↑ Y/Y)
Investment income
$3,620K
(10.50%↑ Y/Y)
Interest income from
licensing
$19K
(-24.00%↓ Y/Y)
Revenues
$29,733K
(22.88%↑ Y/Y)
Interest expense
$13,169K
(1505.98%↑ Y/Y)
Total operating
expenses
$82,144K
(-4.79%↓ Y/Y)
Other operating
expenses
-$65K
(-275.68%↓ Y/Y)
General and
administrative
$20,253K
(4.28%↑ Y/Y)
Research and development
$56,101K
(3.07%↑ Y/Y)
Cost of license and
royalty revenues
$5,725K
Back
Back
Income Statement
source: myfinsight.com
REGENXBIO Inc. (RGNX)
REGENXBIO Inc. (RGNX)